Accessibility Statement
Accessibility

The South West Academic Health Science Network

MENUMENU
  • Home
  • Who We Are
    • Meet the team
      • Core Staff
      • Board Members
      • Associate Network
    • Partners
      • Member Organisations
      • The AHSN Network
    • Join Us
      • Become a Member
      • Vacancies
      • Getting people involved
  • Who We Are
    • Meet the team
      • Core Staff
      • Board Members
      • Associate Network
    • Partners
      • Member Organisations
      • The AHSN Network
    • Join Us
      • Become a Member
      • Vacancies
      • Getting people involved
  • What we do
    • Spreading Innovation
    • Innovation Exchange
    • Working in collaboration
  • What we do
    • Spreading Innovation
    • Innovation Exchange
    • Working in collaboration
  • COVID-19 Programmes
    • Improving Patient Safety
    • Supporting Digital-First Pathways
    • Addressing health inequalities
  • COVID-19 Programmes
    • Improving Patient Safety
    • Supporting Digital-First Pathways
    • Addressing health inequalities
  • News & Events
    • News
    • Events
    • Past Events
  • News & Events
    • News
    • Events
    • Past Events
  • Resources
    • Case Studies
    • Publications
  • Resources
    • Case Studies
    • Publications
  • Contact Us
    • Find Us
  • Contact Us
    • Find Us
You are here: Home > General > Launch of phase 3 of the Pathway Transformation Fund

Launch of phase 3 of the Pathway Transformation Fund

Posted On 09 February 2021

Applications for phase 3 of the Pathway Transformation Fund (PTF) are now open.

The Pathway Transformation Fund supports NHS organisations to increase adoption of the 2020/21 Rapid Uptake Products (RUPs), which are:

• Lipid Management: High Intensity Statins, Ezetimibe and PCSK9 inhibitors.
• Measuring fractional exhaled nitric oxide (FeNO) concentration in asthma: products NIOX VERO and NObreath.
• Biologics for treating severe asthma: Reslizumab, Benralizumab, Mepolizumab and Omalizumab.

The PTF can help providers overcome practical obstacles to introducing these products. PTF funding can be used for many purposes, including:

• Contributing to set-up costs such as training and accreditation of staff.
• Supporting pathway redesign and/or business support expertise.
• Providing funding for specialist nurses and clinical staff needed to implement a new part of the procedure.
• Covering double running costs.
• Covering capital costs.

NHS organisations will be able to submit PTF applications until midday, 30 April 2021.

Applications should be developed and submitted with the support of your RUP lead. Organisations based in Devon, Cornwall or Somerset requiring more information or interested in beginning an application process should contact the SWAHSN RUP lead, Steve Johnson-Wood, Steve.Johnson-Wood@swahsn.com.

SHARE THIS

SW AHSN newsletter mailer signup graphic

Recent posts

  • March 2021
  • February 2021
  • January 2021
  • December 2020

Archive

  • 2021
  • 2020
  • 2019

Categories

Top

South West Academic
Health Science Network

(SW AHSN)

Vantage Point
Pynes Hill
Exeter, EX2 5FD

Code of Conduct | Terms & Conditions
Cookies | Sitemap
VAT Number: 175936368
Company number: 08495463
Designed by: StudioZumfelde

linkedintwittermail

This site uses cookies: Find out more.